1
|
Okoh OS, Yakubu A, Adegboyega AE, Uti DE, Obeten UN, Agada SA, Oluwaloni F, Johnson GI, Mela LP, Asomadu RO, Iwaloye O, Johnson TO, Orji OU. Identification of some bioactive compounds from Trignonella foenumgraecum as possible inhibitors of PPARϒ for diabetes treatment through molecular docking studies, pharmacophore modelling and ADMET profiling: An in-silico study. PLoS One 2023; 18:e0284210. [PMID: 37200359 DOI: 10.1371/journal.pone.0284210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2023] [Accepted: 03/24/2023] [Indexed: 05/20/2023] Open
Abstract
Oral antidiabetic agents including the peroxisome proliferator-activated receptor gamma (PPARγ) agonists are available for the clinical management of diabetes mellitus (DM) but most are characterized by many adverse effects. In this study, we explore the antidiabetic properties of phytoconstituents from Trigonellafeonumgraecum (Fabaceae) as potential agonist of PPARγ; using in silico molecular docking, molecular mechanics generalized surface area (MM/GBSA)free binding energy prediction, Pharmacophore modeling experiment, and Pharmacokinetic/ toxicity analysis. One hundred and forty (140) compounds derived from Trigonellafeonumgraecum were screened by molecular docking against protein target PDB 3VI8. Results obtained from binding affinity (BA) and that of binding free energy (BFE) revealed five 5 compounds; arachidonic acid (CID_10467, BA -10.029, BFE -58.9), isoquercetin (CID_5280804, BA -9.507kcal/mol, BFE -56.33), rutin (CID_5280805, BA -9.463kcal/mol, BFE -56.33), quercetin (CID_10121947, BA -11.945kcal/mol, BFE -45.89) and (2S)-2-[[4-methoxy-3-[(pyrene-1-carbonylamino)methyl]phenyl]methyl]butanoic acid (CID_25112371, BA -10.679kcal/mol, BFE -45.73); and were superior to the standard; Rosiglitazone with a docking score of -7.672. Hydrogen bonding was notable in the protein-ligand complex interaction, with hydrophobic bond, polar bond and pipi stacking also observed. Their Pharmacokinetic/ toxicity profile showed varying druggable characteristics, but; arachidonic acid had the most favorable characteristics. These compounds are potential agonists of PPARγ and are considered as antidiabetic agents after successful experimental validation.
Collapse
Affiliation(s)
| | | | - Abayomi Emmanuel Adegboyega
- Department of Biochemistry, Faculty of Basic Medical Science, University of Jos, Jos, Nigeria
- Jaris Computational Biology Centre, Jos, Nigeria
| | - Daniel Ejim Uti
- Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, Federal University of Health Sciences, Otukpo, Benue State, Nigeria
| | - Uket Nta Obeten
- Department of Chemistry/Biochemistry and Molecular Biology, Alex Ekwueme Federal University, Ndufu-Alike Ikwo, Abakaliki, Ebonyi State, Nigeria
| | - Samuel Ali Agada
- Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, Federal University of Health Sciences, Otukpo, Benue State, Nigeria
| | - Folusho Oluwaloni
- Department of Biotechnology, Federal Institute of Industrial Research, Oshodi, Lagos, Nigeria
| | - Grace Inioluwa Johnson
- Jaris Computational Biology Centre, Jos, Nigeria
- Faculty of Medical Sciences, College of Health Sciences, University of Jos, Jos, Nigeria
| | - Leonard Paul Mela
- Department of Clinical Pharmacology and Therapeutics, College of Medical Sciences, University of Maiduguri, Maiduguri, Nigeria
| | | | - Opeyemi Iwaloye
- Jaris Computational Biology Centre, Jos, Nigeria
- Bioinformatics and molecular biology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo, Nigeria
| | - Titilayo Omolara Johnson
- Department of Biochemistry, Faculty of Basic Medical Science, University of Jos, Jos, Nigeria
- Jaris Computational Biology Centre, Jos, Nigeria
| | - Obasi Uche Orji
- Department of Biochemistry, Faculty of Science, Ebonyi State University, Abakaliki, Ebonyi State, Nigeria
| |
Collapse
|
2
|
Amadi PU, Agomuo EN, Amadi JA, Bob-Chile Agada AI, Njoku UC, Ogunwa CS, Odika PC, Osuoha JO, Ogbolosingha AJ, Adumekwe CW, Chigbu IN. Efficacy of using walnuts as statin adjuvants in hypertension management. Clin Exp Hypertens 2022; 44:419-426. [DOI: 10.1080/10641963.2022.2065287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- Peter U. Amadi
- Department of Biochemistry, Imo State University, Owerri, Nigeria
| | | | - Joy A. Amadi
- Department of Nutrition and Dietetics, Imo State University, Owerri, Nigeria
| | | | - Uche C. Njoku
- Department of Biochemistry, University of Port Harcourt, Choba, Nigeria
| | - Chinedu S. Ogunwa
- Chemistry Biochemistry & molecular Biology, Federal University Ndufu Alike Ikwo, Achoro-Ndiagu, Nigeria
| | - Prince C. Odika
- Department of Biochemistry, Imo State University, Owerri, Nigeria
| | - Justice O. Osuoha
- Biochemistry Unit, Laboratory Science Technology, Imo Polytechnic Umuagwo, Umuagu, Nigeria
| | | | | | - Ifeyinwa N. Chigbu
- Department of Biochemistry, Federal University of Technology, Owerri, Nigeria
| |
Collapse
|
4
|
Xiong H, Wang J, Ran Q, Lou G, Peng C, Gan Q, Hu J, Sun J, Yao R, Huang Q. Hesperidin: A Therapeutic Agent For Obesity. DRUG DESIGN DEVELOPMENT AND THERAPY 2019; 13:3855-3866. [PMID: 32009777 PMCID: PMC6859214 DOI: 10.2147/dddt.s227499] [Citation(s) in RCA: 87] [Impact Index Per Article: 17.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/19/2019] [Accepted: 10/23/2019] [Indexed: 12/15/2022]
Abstract
Obesity is a chronic metabolic disease caused by multiple factors and is considered to be a risk factor for type 2 diabetes, cardiovascular disease, hypertension, stroke and various cancers. Hesperidin, a flavanone glycoside, is a natural phenolic compound with a wide range of biological effects. Mounting evidence has demonstrated that hesperidin possesses inhibitory effect against obesity diseases. Our review discusses mechanisms of hesperidin in the treatment of obesity. Hesperidin regulates lipid metabolism and glucose metabolism by mediating AMPK and PPAR signaling pathways, directly regulates antioxidant index and anti-apoptosis, and indirectly mediates NF-κB signaling pathway to regulate inflammation to play a role in the treatment of obesity. In addition, hesperidin-enriched dietary supplements can significantly improve symptoms such as postprandial hyperglycemia and hyperlipidemia. Further clinical trials are also required for confirming lipid-lowering efficacy of this natural flavonoid and evaluating its safety profile.
Collapse
Affiliation(s)
- Haijun Xiong
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China
| | - Jin Wang
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China
| | - Qian Ran
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China
| | - Guanhua Lou
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China
| | - Chengyi Peng
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China
| | - Qingxia Gan
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China
| | - Ju Hu
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China
| | - Jilin Sun
- Sichuan Fuzheng Pharmaceutical Co. Ltd, Sichuan, People's Republic of China
| | - Renchuan Yao
- Sichuan Fermentation Traditional Chinese Medicine Engineering Research Center, Chengdu, People's Republic of China
| | - Qinwan Huang
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China.,State Key Laboratory of Traditional Chinese Medicine Processing Technology, State Administration of Traditional Chinese Medicine, Chengdu 611137, People's Republic of China
| |
Collapse
|